Streetbeat News

Partnerships

AAPL

AMC

CMCSA

DIS

MAT

MSFT

TSLA

WBD

Wikipedia's top 25 most viewed pages in 2023 included various topics, with ChatGPT leading the list. Microsoft's investment in OpenAI and integration of ChatGPT into its platforms contributed to the interest. Cricket and soccer were popular sports topics, while movies like 'Barbie' and 'Oppenheimer' were among the top pages. Apple benefited from Messi's move to MLS, Mattel and Warner Bros. Discovery saw success with 'Barbie', and Comcast's 'Oppenheimer' was a top film. Disney had two films in the top pages but no billion-dollar hits. Taylor Swift's popularity boosted AMC's performance, and Elon Musk remained a highly searched personality.

Portfolio Pulse from Chris Katje

December 19, 2023 | 4:18 pm

HUT

Hut 8 Mining Corp. (NASDAQ:HUT) shares have surged over 55% in the past five days, with continued gains on Tuesday. The increase follows the announcement of an agreement to build and install mining operations in Cedarvale, TX, as part of the Celsius Network bankruptcy proceedings. The new site will support approximately 66,000 miners with over 215 MW of energy. Hut 8's president highlighted the company's managed services business and its efficiency in setting up and optimizing mining operations as key to securing the project. The stock is experiencing heavy trading volume, surpassing its 100-day average, and is trading above its 50-day moving average.

Portfolio Pulse from Erica Kollmann

December 19, 2023 | 4:17 pm

NVO

Novo Nordisk A/S (NYSE:NVO) has collaborated with IndiaMART to remove unauthorized listings of its weight-loss drug Wegovy in India. IndiaMART took action after discussions with Novo Nordisk, who is the sole patent holder of semaglutide, the active ingredient in Wegovy and diabetes medication Ozempic. The company's legal team in India is working to establish a framework to notify and remove counterfeit listings to curb illegal sales. Despite the challenges in tracing illegal sellers, Novo Nordisk regularly monitors and engages with platforms to prevent unauthorized sales. IndiaMART has been listed on a U.S. government agency's 'Notorious Markets' list for 2022, indicating ongoing issues with counterfeit goods. NVO shares saw a 1.46% increase to $100.43.

Portfolio Pulse from Vandana Singh

December 19, 2023 | 3:53 pm

AZN

CGEN

GILD

Compugen Ltd's stock (CGEN) is trading higher following an agreement with Gilead Sciences Inc (GILD) to license its COM503 drug candidate, a potential first-in-class antibody for cancer immunotherapy. Gilead will pay Compugen $60 million upfront, $30 million upon IND clearance expected in 2024, and up to $758 million in additional payments, plus royalties on net sales. The deal is anticipated to reduce Gilead's 2023 EPS by $0.03-$0.05. Compugen also stands to receive a $10 million milestone payment from AstraZeneca (AZN) for the dosing of the first patient in a trial derived from its COM902 antibody.

Portfolio Pulse from Vandana Singh

December 19, 2023 | 3:36 pm

FCEL

XOM

FuelCell Energy Inc (FCEL) reported a 43% year-over-year decline in Q4 FY23 revenue to $22.46 million, missing consensus estimates. EPS loss improved to $(0.07), beating estimates. Gross and operating losses narrowed, and adjusted EBITDA loss improved. The company's backlog decreased by 5.7% YoY. FCEL began commercial operations of a hydrogen tri-generation platform in Long Beach, and Exxon Mobil Corporation (XOM) plans to build a pilot plant using FCEL's technology. FCEL shares dropped by 5.22%.

Portfolio Pulse from Akanksha Bakshi

December 19, 2023 | 3:26 pm

AFRM

WMT

Affirm Holdings Inc (NASDAQ:AFRM) stock is trading higher after announcing the expansion of its services to include self-checkout at Walmart Inc (NYSE:WMT) stores. This service will be available for the holiday season at over 4,500 U.S. locations. The expansion allows Walmart shoppers to use Affirm's flexible pay-over-time options at self-checkout kiosks, online, and in Walmart apps, including Vision and Auto Centers. Affirm's research indicates a strong consumer demand for buy now, pay later options, with a significant percentage of consumers likely to delay or avoid purchases without such options. Analysts have mixed ratings on Affirm, with a consensus price target of $26.67.

Portfolio Pulse from Adam Eckert

December 19, 2023 | 3:05 pm

IFF

IFF (NYSE:IFF) is expanding its partnership with Kemira to commercialize a new portfolio of renewable polymers derived from IFF's Designed Enzymatic Biomaterials (DEB) technology. These biopolymers, made from plant sugars, will be produced at industrial scale and integrated into Chemigate Ltd's biorefinery in Finland, operational by mid-2024. The collaboration aims to supply alternatives to fossil-based synthetic polymers for various markets, including pulp, paper, packaging, and water treatment. IFF's DEB technology, initially launched for home and personal care markets, will now offer high-performance material solutions to promote a circular bioeconomy. The materials will expand IFF's AURIST™ biopolymers and Nuvolve® engineered polysaccharides product lines.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 3:03 pm

CGEN

GILD

Compugen's stock price has risen following the announcement of an exclusive licensing agreement with Gilead for its pre-clinical immunotherapy program.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:17 pm

AFRM

WMT

Affirm Holdings, Inc. (AFRM) shares have risen following the announcement of the expansion of its services to include self-checkout at Walmart stores.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:07 pm

GOVX

GeoVax Labs, Inc. has expanded its License Agreement with the NIH to include Mpox and smallpox in its vaccine development program. The agreement allows the use of U.S. HHS materials and patents in combination with GeoVax's technology to create vaccines for COVID-19, Mpox, and smallpox. Financial details of the agreement were not revealed.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 2:05 pm